A. Juvekar

发表

Remarkable anti-breast cancer activity of ferrocene tagged multi-functionalized 1,4-dihydropyrimidines.

Rajashri S. Salunkhe, G. Rashinkar, S. Khanapure, 2013, European journal of medicinal chemistry.

Design and synthesis of (S)- and (R)-enantiomers of [4-(2-hydroxy-1-phenylethylimino)pent-2-ol]dimethyltin(iv) and 2,2-dimethyl-4-phenyl-1,3,2-oxazastannolidine: in vitro antitumor activity against human tumor cell lines and in vivo assay of (S)-enantiomers.

S. Tabassum, F. Arjmand, S. Zingde, 2013, Dalton transactions.

Synthesis of Aryl‐Substituted Naphthalene‐Linked Pyrrolobenzodiazepine Conjugates as Potential Anticancer Agents with Apoptosis‐Inducing Ability

S. Sen, M. J. Ramaiah, S. Pushpavalli, 2011, ChemMedChem.

Effect of induced acidosis on cytotoxicity of anticancer drugs.

A. Juvekar, M. Chitnis, M. Adwankar, 1991, Selective cancer therapeutics.

Phosphonate-linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis, DNA-binding affinity and cytotoxicity.

S. Sen, A. Kamal, S. Zingde, 2008, Bioorganic & medicinal chemistry.

Carbohydrate-conjugate heterobimetallic complexes: synthesis, DNA binding studies, artificial nuclease activity and in vitro cytotoxicity.

S. Tabassum, F. Arjmand, S. Zingde, 2011, Carbohydrate research.

Establishment of a Tongue Squamous Cell Carcinoma Cell Line from Indian Gutka Chewer

M. Mahimkar, S. Kane, A. Juvekar, 2014 .

Synthesis of carbohydrate-conjugate heterobimetallic Cu(II)-Sn(2)(IV) and Zn(II)-Sn(2)(IV) complexes; their interactions with CT DNA and nucleotides; DNA cleavage, in-vitro cytotoxicity.

S. Tabassum, F. Arjmand, S. Zingde, 2010, European journal of medicinal chemistry.

Synthesis and evaluation of novel N-substituted-6-methoxynaphthalene-2-carboxamides as potential chemosensitizing agents for cancer.

A. Juvekar, C. Viswanathan, T. Lokhande, 2008, Chemical & pharmaceutical bulletin.

Preclinical Models for Evaluating Topoisomerase I-Targeted Drugs

P. Houghton, C. Stewart, A. Juvekar, 2005 .

Synthesis and Evaluation of L-Glutamic acid Analogs as Potential Anticancer Agents

A. Juvekar, A. Jain, S. Deb, 2008, Indian journal of pharmaceutical sciences.

IN VITRO ANTICANCER ACTIVITY OF ARGEMONE MEXICANA L. SEEDS AND ALSTONIA SCHOLARIS (L.) R. BR. BARK ON DIFFERENT HUMAN CANCER CELL LINES

N. Chandra, N. Mumbai, A. Juvekar, 2014 .

1,2,4-benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis, DNA-binding affinity and cytotoxicity.

S. Sen, A. Kamal, S. Zingde, 2007, Bioorganic & medicinal chemistry letters.

In vitro chemosensitivity profile of oral squamous cell cancer and its correlation with clinical response to chemotherapy.

A. D'cruz, K. Pathak, P. Parikh, 2007, Indian journal of cancer.

Synthesis and characterization of glycoconjugate tin(IV) complexes: In vitro DNA binding studies, cytotoxicity, and cell death

S. Sen, S. Tabassum, F. Arjmand, 2011 .

Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).

A. Juvekar, M. Chitnis, 1991, Neoplasma.

Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.

Hemant Kumar Srivastava, Farheen Sultana, Subrata Sen, 2010, Bioorganic & medicinal chemistry.

In Vitro Anticancer Activity of Monosubstituted Chalcone Derivatives

A. Juvekar, C. Krishna, Priyanka Sathe, 2014 .

Synthesis of 1,2,3-triazole-linked pyrrolobenzodiazepine conjugates employing 'click' chemistry: DNA-binding affinity and anticancer activity.

Ahmed Kamal, N Shankaraiah, Subrata Sen, 2008, Bioorganic & medicinal chemistry letters.

Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents.

S. Sen, A. Kamal, M. J. Ramaiah, 2010, European journal of medicinal chemistry.

Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.

S. Sen, A. Kamal, S. Pushpavalli, 2010, Bioorganic & medicinal chemistry letters.

Synthesis, DNA-binding ability and evaluation of antitumour activity of triazolo[1,2,4]benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.

S. Sen, A. Kamal, S. Zingde, 2008, Bioorganic & medicinal chemistry.

Carbazole–pyrrolo[2,1-c][1,4]benzodiazepine conjugates: design, synthesis, and biological evaluation

M. N. Rao, G. N. Sastry, A. Kamal, 2011 .

Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates.

G. N. Sastry, A. Kamal, M. J. Ramaiah, 2010, Bioorganic & medicinal chemistry.

Synthesis, anticancer activity and mitochondrial mediated apoptosis inducing ability of 2,5-diaryloxadiazole-pyrrolobenzodiazepine conjugates.

S. Sen, M. J. Ramaiah, S. Pushpavalli, 2010, Bioorganic & medicinal chemistry.

Design, Synthesis and Biological Activity of A-C8/C-C2-Linked 6-Chloropurine-Pyrrolobenzodiazepine Hybrids as Anticancer Agents

S. Sen, N. Shankaraiah, A. Kamal, 2007 .

Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.

A. Kamal, S. Zingde, A. Juvekar, 2007, Bioorganic & medicinal chemistry.

Remarkable DNA binding affinity and potential anticancer activity of pyrrolo[2,1-c][1,4]benzodiazepine-naphthalimide conjugates linked through piperazine side-armed alkane spacers.

A. Kamal, S. Zingde, A. Juvekar, 2008, Bioorganic & medicinal chemistry.

Molecular Encapsulation of Thalidomide with Sulfobutyl Ether-7 β-Cyclodextrin for Immediate Release Property: Enhanced In Vivo Antitumor and Antiangiogenesis Efficacy in Mice

A. Juvekar, M. Saraf, P. Tayade, 2008, Drug development and industrial pharmacy.

In vitro and in vivo evaluation of a standardized Curcuma longa Linn formulation in cervical cancer

A. Juvekar, Ashok D B Vaidya, A. Amonkar, 2021, Journal of Ayurveda and integrative medicine.

Design, Synthesis and Evaluation of Novel 1-(Substituted Acetyl)-4-(10-Bromo-8-Chloro-5,6-Dihydro-11H-Benzo[5,6]Cyclohepta[1,2-B]Pyridine-11-Ylidene)piperidines as Antitumor Agents and Farnesyl Protein Transferase Inhibitors

P. Ambre, A. Juvekar, C. Viswanathan, 2010, Indian journal of pharmaceutical sciences.

In vitro modulation of adriamycin and mitoxantrone cytotoxicity by hyperthermia and diazepam, in human chronic myeloid leukemia cells.

A. Juvekar, S. Advani, M. Chitnis, 1987, Neoplasma.

Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells.

A. Juvekar, S. Advani, M. Chitnis, 1986, Anticancer research.

Effect of mitoxantrone on human chronic myeloid leukemia cells in vitro, combined with hyperthermia.

A. Juvekar, S. Advani, M. Chitnis, 1986, Neoplasma.

Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro.

A. Juvekar, S. Advani, M. Chitnis, 1991, Selective cancer therapeutics.

Selenium (Se) cytotoxicity in drug sensitive and drug resistant murine tumour.

J. Shallom, A. Juvekar, M. Chitnis, 1995, Cancer biotherapy.

Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin‐cyclodextrin binary system

A. Juvekar, M. Saraf, P. Tayade, 2006, The Journal of pharmacy and pharmacology.

Chemosensitivity of advanced larynx carcinoma cells in vitro and significance of multidrug resistance markers in these tumors.

A. D'cruz, A. Juvekar, S. Pradhan, 1998, Cancer biotherapy & radiopharmaceuticals.

Effect of cisplatin-based chemotherapy on emergence of cisplatin resistance, and its correlation with intracellular glutathione levels and accumulation of p53 protein in human ovarian cancer.

A. Juvekar, H. Tongaonkar, M. Adwankar, 2000, Cancer biotherapy & radiopharmaceuticals.

Inhibition of DNA biosynthesis by vincristine and pentoxifylline in murine P388 leukemia cells resistant to doxorubicin.

A. Juvekar, M. Chitnis, A. Viladkar, 1990, Neoplasma.

Expression of the multidrug transporter P-glycoprotein and in vitro chemosensitivity: correlation with in vivo response to chemotherapy in acute myeloid leukemia.

U. Hegde, A. Juvekar, S. Chavan, 1991, Selective cancer therapeutics.